FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

QS Violations in Dongguan Rainbow Tech Inspection

FDA warns Chinas Dongguan Rainbow Tech Electronic & Plastics Co. about Quality System Regulation violations in its manufacturing of manual emergency v...

latest-news-card-1
Human Drugs

Report on Ways to Cut Reliance on Foreign Drugs

The Senate Special Committee on Aging releases a report with six recommendations for reducing the use of foreign-made drugs for seniors.

latest-news-card-1
Human Drugs

Makary Details DTC Enforcement Crackdown on Podcast

FDA commissioner Marty Makary addresses during a podcast the agencys significant shift in enforcement policy directed at pharmaceutical advertis...

latest-news-card-1
Human Drugs

FDA Still Finding Issues at Nephron Pharmaceuticals

A South Carolina newspaper reports that the latest FDA inspection at Nephron Pharmaceuticals found the company still has significant quality issues.

Biologics

Moderna Quits CMV Vaccine After Phase 3 Failure

Moderna stops the development of its congenital cytomegalovirus vaccine after it failed to meet the primary endpoint in a large Phase 3 trial.

latest-news-card-1
Human Drugs

3rd Patient-Focused Drug Development Guidance

FDA publishes the third in a series of guidances on aspects of collecting patient experience data to be used in medical product development and regula...

latest-news-card-1
Biologics

sBLA for PadcevKeytruda Combo in Bladder Cancer

FDA accepts for priority review an Astellas supplemental BLA for Padcev (enfortumab vedotin-ejfv) in combination with Mercks Keytruda (pembrolizumab) ...

latest-news-card-1
Human Drugs

Fast Track for Myosin Glioblastoma Drug

FDA awards a fast track designation to Myosin Therapeutics and its investigational drug MT-125 for treating brain cancer.

latest-news-card-1
Medical Devices

QS, MDR, UDI Issues in Levo AG Inspection

FDA warns Switzerlands Levo AG about Quality System, Medical Device Reporting, and Unique Device Identifier violations in its production of several wh...

Human Drugs

Repeat CGMP Violations at Guangxi Yulin

A 3/17-3/21 FDA inspection at the Guangxi Yulin Pharmaceutical Group drug manufacturing facility in Yulin, Guangxi, China, found repeated significant ...